Table 3.
Relative risks of each outcome in the intervention group compared to the control group.
| Outcome | ARR | 95% CI | p | RR | 95% CI | p |
|---|---|---|---|---|---|---|
| UGIH | 0.33 | (0.007–14.95) | 0.569 | 0.58 | (0.05–6.42) | 0.659 |
| Peptic lesions | 0.78 | (0.44–1.38) | 0.407 | 0.90 | (0.55–1.48) | 0.694 |
| Ulcers | 0.58 | (0.07–4.31) | 0.592 | 0.77 | (0.13–4.64) | 0.781 |
| Esophagitis | 1.49 | (0.48–4.63) | 0.489 | 1.49 | (0.55–4.02) | 0.423 |
| Gastritis | 0.67 | (0.32–1.41) | 0.291 | 0.77 | (0.41–1.46) | 0.433 |
| Duodenitis | 0.58 | (0.80–1.66) | 0.309 | 0.77 | (0.31–1.90) | 0.579 |
| PHG | 2.05 | (0.84–5.02) | 0.116 | 1.51 | (0.66–3.45) | 0.324 |
| Dyspeptic symptoms | 1.78 | (0.56–5.66) | 0.326 | 2.13 | (0.79–5.77) | 0.135 |
| Musculoskeletal pain | 1.24 | (0.28–5.47) | 0,777 | 1.74 | (0.49–6.18) | 0.388 |
| Arthralgia | 1.73 | (0.29–10.09) | 0.543 | 1.55 | (0.34–6.93) | 0.565 |
| Myalgia | 1.05 | (0.14–7.94) | 0.962 | 2.32 | (0.42–12.71) | 0.324 |
ARR: Adjusted relative risk of each outcome in the intervention group compared to the control group, adjusted for gender, age, ethnicity and prior UGIH, MELD score, gastric varices, PHG degree, esophagitis, gastritis, ulcer, duodenitis and degree of esophageal varices. RR: relative risk. 95% CI: 95% confidence interval. UGIH: upper gastrointestinal hemorrhage; PHG: portal hypertensive gastropathy; MELD: model for end-stage liver disease.